Pyrazol-5-ones
US4032646A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Sep 4, 1975 |
| Grant date | Jun 28, 1977 |
| Priority date | — |
| Expiry date | Sep 4, 1995 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D231/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions useful for effecting diuresis and saluresis and for treating hypertension in humans and animals are produced by combining a pyrazol-5-one of the formula: ##STR1## or a pharmaceutically acceptable nontoxic salt thereof wherein R is hydrogen, lower alkyl or amino; PA1 R.sup.1 is lower alkyl, alkenyl of 2 to 4 carbon atoms, monoaryl or monoaralkyl unsubstituted or substituted in the aryl moiety by 1 or 2 of the same or different substituents selected from the group consisting of lower alkyl, lower alkenyl, lower alkoxy, lower alkenoxy, halogen, nitro, cyano and trifluoromethyl; PA1 X is methylene, ethylene, methylene wherein 1 hydrogen atom is substituted by lower alkyl, or ethylene wherein 1 hydrogen atom is substituted by lower alkyl or 1 hydrogen atom on each of the two carbon atoms is substituted by lower alkyl; PA1 Y is a direct bond, oxygen or sulphur, provided that when X is methylene, Y is a direct bond; and PA1 Z is aryl unsubstituted or nuclear substituted by: PA2 A. 3 halogens; PA2 B. 1 or 2 of the same or different substituents selected from the group consisting of halogen, trifluoromethyl, lower alkyl, lower alkenyl, lower alkoxy, lower alkenox…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.